Furthermore, recurrence‐free survival rates tended to be more favorable in patients with albumin <4.0 g/dL, microscopic vascular invasion, tumor size >2.0 cm, AFP >20 ng/dL, ALT >30 IU/L, T‐Bil >1.0 mg/dL, and liver cirrhosis. This evidence concerns the gene ALB and cirrhosis of liver.